GB1478742A - Pharmaceutical compositions and their preparation - Google Patents
Pharmaceutical compositions and their preparationInfo
- Publication number
- GB1478742A GB1478742A GB2146/75A GB214675A GB1478742A GB 1478742 A GB1478742 A GB 1478742A GB 2146/75 A GB2146/75 A GB 2146/75A GB 214675 A GB214675 A GB 214675A GB 1478742 A GB1478742 A GB 1478742A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dry powder
- bismuth
- pharmaceutical compositions
- jan
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1478742 Bismuth-containing antacids GISTBROCADES NV 17 Jan 1975 [18 Jan 1974] 2146/75 Heading A5B A solid bismuth-containing powder for use in the treatment of peptic ulcer is prepared by spray-drying an aqueous, colloidal solution comprising bismuth citrate, ammonia and a non-toxic polyhydric alcohol e.g. sucrose or maltose, to produce a dry powder. Pharmaceutical compositions for oral administration comprise (1) the dry powder optionally together with pharmaceutically-acceptable carrier(s) and may be in the form of tablets or capsules or (2) a liquid obtained by dissolving the dry powder in water. The liquid starting material optionally contains pepsin, a colouring agent such as carmine, an alkali metal (e.g. sodium or potassium) hydroxide and a preservative.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA00740385A ZA74385B (en) | 1974-01-18 | 1974-01-18 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1478742A true GB1478742A (en) | 1977-07-06 |
Family
ID=25567281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2146/75A Expired GB1478742A (en) | 1974-01-18 | 1975-01-17 | Pharmaceutical compositions and their preparation |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5837284B2 (en) |
AT (1) | AT349150B (en) |
AU (1) | AU485660B2 (en) |
BE (1) | BE824509A (en) |
CA (1) | CA1040532A (en) |
CH (1) | CH622947A5 (en) |
DE (1) | DE2501787A1 (en) |
DK (1) | DK151770C (en) |
ES (1) | ES433908A1 (en) |
FI (1) | FI750113A (en) |
FR (1) | FR2258177B1 (en) |
GB (1) | GB1478742A (en) |
IE (1) | IE40361B1 (en) |
IT (1) | IT1036072B (en) |
LU (1) | LU71668A1 (en) |
NL (1) | NL185130C (en) |
SE (1) | SE437930B (en) |
ZA (1) | ZA74385B (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1983001001A1 (en) * | 1981-09-22 | 1983-03-31 | Gist Brocades Nv | Bismuth containing composition and method for the preparation thereof |
DE3619734A1 (en) * | 1985-06-13 | 1987-02-12 | Barry James Marshall | AGENT FOR TREATMENT OF GASTRONIC DISEASES |
DE3619702A1 (en) * | 1985-06-13 | 1987-02-12 | Barry James Marshall | METHOD AND COMPOSITIONS FOR THE TREATMENT OF STOMESTRAL DISEASES |
US4748113A (en) * | 1985-06-13 | 1988-05-31 | Marshall Barry J | Compositions and methods for the diagnosis of gastrointestinal disorders involving urease |
US4801608A (en) * | 1981-09-22 | 1989-01-31 | Gist-Brocades N. V. | Bismuth containing composition and method for the preparation thereof |
GB2236479A (en) * | 1989-10-04 | 1991-04-10 | Ulso Lab Limited | Preparation of orally administrable bismuth ammonium citrate solutions |
US5192752A (en) * | 1991-01-14 | 1993-03-09 | The Procter & Gamble Company | Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate |
US5256684A (en) * | 1985-06-13 | 1993-10-26 | The Procter & Gamble Company | Methods and compositions for the treatment of gastrointestinal disorders |
US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
US6517809B1 (en) | 1997-05-28 | 2003-02-11 | Barry J. Marshall | Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract |
US6616938B2 (en) | 1994-05-02 | 2003-09-09 | Josman Laboratories, Inc. | Method of making chewing gum containing colloidal bismuth subcitrate |
USD484988S1 (en) | 2001-12-17 | 2004-01-06 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kit with specimen-handling tool |
US6783976B2 (en) | 2001-12-21 | 2004-08-31 | Kimberly-Clark Worldwide, Inc. | Carrier and specimen-handling tool for use in diagnostic testing |
US6902738B2 (en) | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
US6998250B2 (en) | 2001-10-15 | 2006-02-14 | Donald J. McMichael | Method for detecting Helicobacter pylori |
US7008777B2 (en) | 2001-10-15 | 2006-03-07 | Barry J. Marshall | System for the detection of urease and method for using same |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
AU590578B2 (en) * | 1985-04-18 | 1989-11-09 | Procter & Gamble Company, The | Treatment of non-ulcer dyspepsia with bismuth salts |
EP0363502B1 (en) * | 1988-10-08 | 1991-09-25 | Dr. R. Pfleger Chemische Fabrik Gmbh | Liquid formulation containing bismuth, process to prepare it and use thereof |
DE3901508C2 (en) * | 1989-01-19 | 1994-04-07 | Falk Pharma Gmbh | Drug based on a bismuth-containing preparation in solid form |
IT1229502B (en) * | 1989-01-25 | 1991-09-03 | Euroresearch Srl | COMPOSITIONS CONTAINING BISMUTO SUITABLE FOR THERAPEUTIC USE. |
ES2084174T3 (en) * | 1990-07-20 | 1996-05-01 | Tillotts Pharma Ag | PRODUCTS AND PROCESSES FOR THE TREATMENT OF THE FOOD DUCT. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1963781A1 (en) * | 1968-12-23 | 1970-07-09 | Serfontein Willem Jacob | Improved bismuth preparations |
GB1259151A (en) * | 1968-12-23 | 1972-01-05 | Willem Jacob Serfontein | Bismuth complexes |
-
1974
- 1974-01-18 ZA ZA00740385A patent/ZA74385B/en unknown
-
1975
- 1975-01-14 AU AU77293/75A patent/AU485660B2/en not_active Expired
- 1975-01-16 CH CH51075A patent/CH622947A5/en not_active IP Right Cessation
- 1975-01-16 JP JP50007408A patent/JPS5837284B2/en not_active Expired
- 1975-01-17 DE DE19752501787 patent/DE2501787A1/en active Granted
- 1975-01-17 IE IE86/75A patent/IE40361B1/en unknown
- 1975-01-17 DK DK012675A patent/DK151770C/en not_active IP Right Cessation
- 1975-01-17 LU LU71668A patent/LU71668A1/xx unknown
- 1975-01-17 BE BE152481A patent/BE824509A/en not_active IP Right Cessation
- 1975-01-17 FR FR7501521A patent/FR2258177B1/fr not_active Expired
- 1975-01-17 SE SE7500501A patent/SE437930B/en not_active IP Right Cessation
- 1975-01-17 CA CA218,092A patent/CA1040532A/en not_active Expired
- 1975-01-17 AT AT31875A patent/AT349150B/en not_active IP Right Cessation
- 1975-01-17 ES ES433908A patent/ES433908A1/en not_active Expired
- 1975-01-17 GB GB2146/75A patent/GB1478742A/en not_active Expired
- 1975-01-17 NL NLAANVRAGE7500552,A patent/NL185130C/en not_active IP Right Cessation
- 1975-01-17 IT IT67104/75A patent/IT1036072B/en active
- 1975-01-17 FI FI750113A patent/FI750113A/fi not_active Application Discontinuation
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4801608A (en) * | 1981-09-22 | 1989-01-31 | Gist-Brocades N. V. | Bismuth containing composition and method for the preparation thereof |
EP0075992A1 (en) * | 1981-09-22 | 1983-04-06 | Gist-Brocades N.V. | Bismuth containing composition and method for the preparation thereof |
WO1983001001A1 (en) * | 1981-09-22 | 1983-03-31 | Gist Brocades Nv | Bismuth containing composition and method for the preparation thereof |
US5256684A (en) * | 1985-06-13 | 1993-10-26 | The Procter & Gamble Company | Methods and compositions for the treatment of gastrointestinal disorders |
DE3619702A1 (en) * | 1985-06-13 | 1987-02-12 | Barry James Marshall | METHOD AND COMPOSITIONS FOR THE TREATMENT OF STOMESTRAL DISEASES |
US4748113A (en) * | 1985-06-13 | 1988-05-31 | Marshall Barry J | Compositions and methods for the diagnosis of gastrointestinal disorders involving urease |
DE3619733A1 (en) * | 1985-06-13 | 1987-02-12 | Barry James Marshall | AGENT FOR TREATMENT OF GASTRONIC DISEASES |
DE3619734A1 (en) * | 1985-06-13 | 1987-02-12 | Barry James Marshall | AGENT FOR TREATMENT OF GASTRONIC DISEASES |
US5601848A (en) * | 1985-06-13 | 1997-02-11 | The Procter & Gamble Company | Methods for the treatment of gastrointestinal disorders |
GB2236479A (en) * | 1989-10-04 | 1991-04-10 | Ulso Lab Limited | Preparation of orally administrable bismuth ammonium citrate solutions |
GB2236479B (en) * | 1989-10-04 | 1993-06-23 | Ulso Lab Limited | Preparation of orally administrable bismuth ammonium citrate solutions |
US5192752A (en) * | 1991-01-14 | 1993-03-09 | The Procter & Gamble Company | Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate |
US6616938B2 (en) | 1994-05-02 | 2003-09-09 | Josman Laboratories, Inc. | Method of making chewing gum containing colloidal bismuth subcitrate |
US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
US6902738B2 (en) | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
US6517809B1 (en) | 1997-05-28 | 2003-02-11 | Barry J. Marshall | Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract |
US6998250B2 (en) | 2001-10-15 | 2006-02-14 | Donald J. McMichael | Method for detecting Helicobacter pylori |
US7008777B2 (en) | 2001-10-15 | 2006-03-07 | Barry J. Marshall | System for the detection of urease and method for using same |
USD484988S1 (en) | 2001-12-17 | 2004-01-06 | Kimberly-Clark Worldwide, Inc. | Diagnostic test kit with specimen-handling tool |
US6783976B2 (en) | 2001-12-21 | 2004-08-31 | Kimberly-Clark Worldwide, Inc. | Carrier and specimen-handling tool for use in diagnostic testing |
Also Published As
Publication number | Publication date |
---|---|
AU7729375A (en) | 1976-07-15 |
DK151770C (en) | 1989-11-06 |
SE7500501L (en) | 1975-07-21 |
DK151770B (en) | 1988-01-04 |
IT1036072B (en) | 1979-10-30 |
IE40361B1 (en) | 1979-05-09 |
FR2258177B1 (en) | 1978-07-21 |
NL185130C (en) | 1990-02-01 |
FR2258177A1 (en) | 1975-08-18 |
CA1040532A (en) | 1978-10-17 |
LU71668A1 (en) | 1975-06-24 |
DE2501787A1 (en) | 1975-07-24 |
DE2501787C2 (en) | 1987-11-12 |
AU485660B2 (en) | 1977-07-28 |
SE437930B (en) | 1985-03-25 |
ZA74385B (en) | 1975-08-27 |
CH622947A5 (en) | 1981-05-15 |
JPS5837284B2 (en) | 1983-08-15 |
NL185130B (en) | 1989-09-01 |
NL7500552A (en) | 1975-07-22 |
IE40361L (en) | 1975-07-18 |
JPS50116623A (en) | 1975-09-12 |
BE824509A (en) | 1975-07-17 |
ATA31875A (en) | 1978-08-15 |
AT349150B (en) | 1979-03-26 |
DK12675A (en) | 1975-09-15 |
ES433908A1 (en) | 1976-11-16 |
FI750113A (en) | 1975-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1478742A (en) | Pharmaceutical compositions and their preparation | |
GB1405088A (en) | Slow release formulation | |
IL47656A0 (en) | Sulphonic acid salts of s-adenosilmethionine,their preparation and pharmaceutical compositions containing them | |
GB1465347A (en) | Composition | |
HK52380A (en) | Aqueous preparations of dyestuffs or optical brighteners insoluble to difficultly soluble in water as well as the use thereof | |
GB1530106A (en) | Stannous pyrophosphate technetium-99m compositions | |
SE311208B (en) | ||
GB1344042A (en) | Dentrifrices | |
GB1256968A (en) | ||
IT1229502B (en) | COMPOSITIONS CONTAINING BISMUTO SUITABLE FOR THERAPEUTIC USE. | |
GB1486687A (en) | Iron-resin adsorbate | |
GB1338071A (en) | Pharmaceutical iron preparations | |
GB1422193A (en) | Pharmaceutical compositions | |
ES404959A1 (en) | Aqueous doxycycline compositions | |
JPS5492618A (en) | Poultice | |
ES314805A1 (en) | Effervescent tablet | |
GB1449146A (en) | Prostaglandins and the preparation thereof | |
JPS4814656B1 (en) | ||
GB524756A (en) | Medicinal preparations of magnesium hydroxide and precess of obtaining the same | |
JPS55108814A (en) | Preparation of stable, easily soluble, amorphous magnesium citrate powder for medical use | |
GB1504767A (en) | Antibiotic compositions | |
GB1190838A (en) | Improvements in or relating to Dental Impression Materials | |
GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
GB1288892A (en) | ||
GB1032173A (en) | A method of stabilising aqueous solutions of tin ú¿óú® salts, and dental preparations containing such stabilised solutions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
704A | Declaration that licence is not available as of right for an excepted use (par. 4a/1977) | ||
732 | Registration of transactions, instruments or events in the register (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19940117 |